A shadow economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Express Worries
Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Several experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic content and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step guides for preparing or administering at residence.
Within minutes of joining one group, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.
Item Details and Costs
Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for Telegram stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously seen individuals injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to potentially significant medical dangers”.
